# Terbinafine

NDC: 70518-4323
Generic name: Terbinafine
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250328
Marketing ended: 20260930
FDA application: ANDA077533

## Active ingredients

- TERBINAFINE HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-4323"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-4323
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79ddc2e9-ea43-41a2-a5b0-b13b3eaf7d7a